Spruce Biosciences Inc. (SPRB)
NASDAQ · Healthcare
Spruce Biosciences Inc. Revenue 2022–2025
Spruce Biosciences Inc. annual/quarterly revenue history and growth rate from 2022 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Spruce Biosciences Inc. revenue for the quarter ending September 30, 2025 was 0, a 100.00% decrease year-over-year.
- Spruce Biosciences Inc. revenue for the twelve months ending September 30, 2025 was 602000, a 93.20% decrease year-over-year.
- Spruce Biosciences Inc. annual revenue for 2025 was 0, a 100.00% decrease from 2024.
- Spruce Biosciences Inc. annual revenue for 2024 was 4.9 M, a 51.32% decrease from 2023.
- Spruce Biosciences Inc. annual revenue for 2023 was 10.1 M.
- Spruce Biosciences Inc. annual revenue for 2022 was 0.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Spruce Biosciences Inc. (SPRB) — Frequently Asked Questions
Spruce Biosciences Inc. (SPRB) is a publicly traded US company. It has a market capitalization of $36M. Explore SPRB's stock price, financial statements, earnings history, margins and key ratios below.
What is Spruce Biosciences Inc.'s market cap?
Spruce Biosciences Inc. (SPRB) has a market capitalization of $36M.
What is the SPRB stock price?
SPRB trades at $47.13 (-3.88% on the day).
Is SPRB profitable?
In fiscal 2025, Spruce Biosciences Inc. reported net income of -$39M.